MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 69 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $339,352 | +8.2% | 10,739 | -11.5% | 0.21% | +10.8% |
| Q2 2023 | $313,777 | -23.6% | 12,129 | -29.0% | 0.19% | -17.7% |
| Q1 2023 | $410,478 | +25.4% | 17,089 | +1.8% | 0.23% | +32.2% |
| Q4 2022 | $327,405 | +26.4% | 16,790 | +36.3% | 0.17% | +66.0% |
| Q3 2022 | $259,000 | +9.7% | 12,318 | +1.5% | 0.10% | +18.4% |
| Q2 2022 | $236,000 | -4.1% | 12,137 | +8.7% | 0.09% | -20.9% |
| Q1 2022 | $246,000 | +30.9% | 11,161 | -5.6% | 0.11% | +54.9% |
| Q4 2021 | $188,000 | -21.3% | 11,817 | -1.4% | 0.07% | -32.4% |
| Q3 2021 | $239,000 | +9.6% | 11,984 | -4.9% | 0.10% | +16.7% |
| Q2 2021 | $218,000 | -12.1% | 12,602 | +0.7% | 0.09% | -14.3% |
| Q1 2021 | $248,000 | +15.3% | 12,515 | +1.8% | 0.10% | +18.0% |
| Q4 2020 | $215,000 | -36.0% | 12,292 | -29.6% | 0.09% | -49.4% |
| Q3 2020 | $336,000 | -13.0% | 17,458 | -12.0% | 0.18% | -3.8% |
| Q2 2020 | $386,000 | – | 19,835 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |